Sam Martin
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Sam Martin currently works at Celldex Therapeutics, Inc. as CFO, Secretary, Treasurer & Senior Vice President since 2009.
Formerly, Mr. Martin worked at Alseres Pharmaceuticals, Inc. as Director-Finance & Corporate Compliance and at Ernst & Young LLP as Audit Manager.
Mr. Martin's education includes an MBA from Boston University and an undergraduate degree from Skidmore College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 32.942 ( 0,04 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.04.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| ALSERES PHARMACEUTICALS, INC. | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Alseres Pharmaceuticals, Inc.
Alseres Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen